Artiva Biotherapeutics (ARTV) Enterprise Value (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Enterprise Value of -$152.6 million for Q1 2026, up 8.04% year-over-year from -$141.3 million in Q1 2025, and down 41.31% quarter-over-quarter from -$108.0 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Enterprise Value (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Enterprise Value for 4 consecutive years, with -$152.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 8.04% year-over-year to -$152.6 million; the TTM figure through Mar 2026 stood at -$152.6 million (up 8.04% YoY), while the FY2025 annual figure was -$108.0 million, up 41.75% from the prior year.
- Enterprise Value eased to -$152.6 million in Q1 2026 per ARTV's latest filing, from -$108.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at $73.1 million in Q2 2024 and bottomed at -$220.5 million in Q3 2025.
- Historically, Enterprise Value has averaged -$99.7 million across 4 years, with a median of -$125.2 million in 2025.
- On a YoY basis, Enterprise Value climbed as much as 236.14% in 2024 and fell as far as 1036.69% in 2024.
- Artiva Biotherapeutics' Enterprise Value stood at $19.8 million in 2023, then slumped by 1036.69% to -$185.4 million in 2024, then jumped by 41.75% to -$108.0 million in 2025, then plunged by 41.31% to -$152.6 million in 2026.
- Business Quant data shows ARTV's Enterprise Value at -$152.6 million in Q1 2026, -$108.0 million in Q4 2025, and -$220.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | -397.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -397.34 Mn |
| Mar 31, 2026 | -152.63 Mn |
| Dec 31, 2025 | -108.01 Mn |
| Sep 30, 2025 | -220.46 Mn |
| Jun 30, 2025 | -142.37 Mn |
| Mar 31, 2025 | -165.96 Mn |
| Dec 31, 2024 | -185.43 Mn |
| Sep 30, 2024 | -146.63 Mn |
| Jun 30, 2024 | 73.10 Mn |
| Mar 31, 2024 | -48.20 Mn |
| Dec 31, 2023 | 19.80 Mn |
| Sep 30, 2023 | -65.89 Mn |
| Jun 30, 2023 | -53.70 Mn |